Abstract
Cognitive-behavioral therapy is an effective intervention for anxiety disorders. However, a significant number of people do not respond or only show partial response even after an adequate course of the treatment. Recent research has shown that the efficacy of the intervention can be improved by the use of cognitive enhancers that augment the core learning processes of cognitive-behavior therapy. This manuscript provides a review of the current state of cognitive enhancers for the treatment of anxiety disorders.
Copyright © 2010 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
Animals
-
Anxiety Disorders / drug therapy*
-
Anxiety Disorders / physiopathology
-
Anxiety Disorders / therapy
-
Benzhydryl Compounds / therapeutic use
-
Caffeine / therapeutic use
-
Clinical Trials as Topic
-
Cognitive Behavioral Therapy
-
Combined Modality Therapy
-
Cycloserine / administration & dosage
-
Cycloserine / therapeutic use
-
Extinction, Psychological / drug effects
-
Extinction, Psychological / physiology
-
Humans
-
Learning / drug effects
-
Learning / physiology
-
Modafinil
-
Neurotransmitter Agents / therapeutic use
-
Nootropic Agents / administration & dosage
-
Nootropic Agents / therapeutic use*
-
Translational Research, Biomedical
-
Yohimbine / therapeutic use
Substances
-
Benzhydryl Compounds
-
Neurotransmitter Agents
-
Nootropic Agents
-
Yohimbine
-
Caffeine
-
Cycloserine
-
Modafinil